Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Apr 15, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Enliven Therapeutics, Inc.
| -6.96K |
$23.34 | -$167,887.52 | -4.03% | 165.86K |
Apr 11 - Apr 15
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
| -1.27K |
$14.50 | -$18,418.68 | -0.88% | 143.47K |
Mar 19
|
Scheduled
| ||||||
Rayzebio, Inc.
| -367.45K |
$62.50 | -$22,965,375.00 | -100.00% |
0
|
Feb 26
| |||||||
Enliven Therapeutics, Inc.
| -1.27K |
$17.42 | -$22,117.43 | -0.87% | 144.74K |
Feb 15
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 13
| |||||||
Enliven Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 13
| |||||||
Enliven Therapeutics, Inc.
| -1.27K |
$16.41 | -$20,839.56 | -0.86% | 146.01K |
Jan 30
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
| -216.00 |
$13.00 | -$2,808.00 | -0.12% | 176.5K |
Dec 21 - Dec 22
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
| -4.28K |
$13.02 | -$55,727.05 | -2.36% | 176.71K |
Dec 19 - Dec 20
|
Scheduled
| ||||||
Rayzebio, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Oric Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 14
| |||||||
Pmv Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Enliven Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 23
| |||||||
Enliven Therapeutics, Inc.
| 218.4K |
—
|
—
|
∞
| 218.4K |
Feb 23
| |||||||
Enliven Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Metacrine, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 18
| |||||||
Gritstone Bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 17
| |||||||
Oric Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 17
| |||||||
Pmv Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 2
| |||||||
Gritstone Bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 18
| |||||||
Oric Pharmaceuticals, Inc.
| -1.39K |
$25.04 | -$34,759.74 | -0.64% | 216.27K |
Sep 14 - Sep 15
|
Scheduled
| ||||||
Oric Pharmaceuticals, Inc.
| -1.08K |
$25.05 | -$27,056.13 | -0.49% | 217.66K |
Sep 10 - Sep 13
|
Scheduled
| ||||||
Oric Pharmaceuticals, Inc.
| -1.09K |
$25.11 | -$27,272.17 | -0.49% | 218.74K |
Sep 7
|
Scheduled
| ||||||
Pmv Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 12
| |||||||
Oric Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 16
| |||||||
Pmv Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 2
| |||||||
Yumanity Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 2
| |||||||
Pmv Pharmaceuticals, Inc.
|
0
|
$139.26 | $832,318.28 |
—
|
0
|
Jun 1
|
Scheduled
| ||||||
Metacrine, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 24
| |||||||
Oric Pharmaceuticals, Inc.
| -1.40K |
$25.15 | -$35,208.03 | -0.63% | 219.83K |
May 20 - May 24
|
Scheduled
| ||||||
Oric Pharmaceuticals, Inc.
| -5.87K |
$25.29 | -$148,581.51 | -2.59% | 221.23K |
May 14 - May 18
|
Scheduled
| ||||||
Oric Pharmaceuticals, Inc.
| -100.00 |
$25.11 | -$2,511.00 | -0.04% | 227.1K |
May 11
|
Scheduled
| ||||||
Oric Pharmaceuticals, Inc.
| -200.00 |
$25.17 | -$5,034.00 | -0.09% | 227.2K |
Apr 28 - Apr 30
|
Scheduled
| ||||||
Oric Pharmaceuticals, Inc.
| -100.00 |
$25.00 | -$2,500.00 | -0.04% | 227.4K |
Apr 1
|
Scheduled
| ||||||
Yumanity Therapeutics, Inc.
| 1.96K |
—
|
—
| +31.81% | 8.12K |
Feb 1
| |||||||
Yumanity Therapeutics, Inc.
| 6.16K |
—
|
—
|
∞
| 6.16K |
Dec 22
| |||||||
Yumanity Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Pmv Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 11
| |||||||
Pmv Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Metacrine, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.